Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis

Indian Journal of Medical Research

Volumn 120, Issue 2, 2004, Pages 100-105

  Srivastava, K ^b   Das, R ^b   Jakhmola, P ^a   Gupta, P ^b   Chauhan, D S ^b   Sharma, V D ^b   Singh, H B ^b   Sachan, A S ^a   Katoch, V M ^b  

^a S N MEDICAL COLLEGE   (India)

^b NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

M. tuberculosis; Mutation detection; rpoB gene analysis; Sensitivity

Indexed keywords

DNA; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; DIAGNOSTIC KIT; DNA EXTRACTION; GENE AMPLIFICATION; GENE MUTATION; GENE PROBE; GENETIC ANALYSIS; HUMAN; HYBRIDIZATION; INDIA; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; WILD TYPE;

ANTIBIOTICS, ANTITUBERCULAR; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; STATISTICS;

EID: 4544269658     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Dye C, Williams BG. Criteria for the control of drug resistant tuberculosis. Proc Natl Acad Sci USA 2000; 97 : 8180-5.
2. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, et al. Global trends in resistance for antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001; 344 : 1294-303.
3. Cohn DL, Bustreo F, Raviglione MC. Drug resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis 1997; 24 (Suppl 1): S121-30.
4. Paramasivan CN. An overview on drug resistant tuberculosis in India. Indian J Tuberc 1998; 45: 73-81.
5. Malhotra B, Pathak S, Vyas L, Katoch VM, Srivastava K, Chauhan DS, et al. Drug susceptibility profile of Mycobacterium tuberculosis isolates at Jaipur. Indian J Med Microbiol 2002; 20: 76-8.
6. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc Lung Dis 1998; 79 : 3-29.
7. Beenhouwer H, Lhiang Z, Jannes G, Mijs W, Machtelinckx L, Rossau R, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis 1995; 76 : 425-30.
8. Bernard PM, Vrioni G, Marinis E. Characterization of rpoB mutation in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol 1998; 36: 20-3.
9. Qian L, Abe C, Lin TP, Yu MC, Cho SN, Wang S, et al. rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries. J Clin Microbiol 2002; 40 : 1091-4.
10. Siddiqi N, Shamim M, Hussain S, Choudhary RK, Ahmed N, Prachee, et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002; 46 : 443-50.
11. Mani C, Selvakumar N, Narayanan S, Narayanan PR. Mutations in the rpoB gene of multi drug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol 2001; 39: 2987-90.
12. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, et al. Advances in the techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
13. WHO Guidelines for surveillance of drug resistance in tuberculosis. Geneva, Switzerland: World Health Organization; 1997 p. 17-8.
14. Srivastava K, Das R, Sharma VD, Singh D, Singh HB, Katoch VM. Relevance of degree of rifampicin resistance in tuberculosis. Indian J Med Microbiol 2001; 19 : 36-9.
15. Paramasivan CN, Chandrasekaran V, Santha T, Sudarsanam NM, Prabhakar R. Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India. Tuber Lung Dis 1993; 74 : 23-7.
16. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-9.
17. Miller LP, Crawford JT, Shinnick TM. The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1994; 38: 805-11.
18. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-50.
19. Morlock GP, Plikaytis BB, Crawford JT. Characterization of spontaneous, in vitro selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv. Antimicrob Agents Chemother 2000; 44 : 3298-301.
20. Vestal AL. Procedure for isolation and identification of mycobacteria. Atlanta, Georgia: U.S. Department of Health Education and Welfare, Centers for Disease Control, 1977 p. 15-95.
21. Yuen LK, Leslie D, Coloe PJ. Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia. J Clin Microbiol 1999; 37: 3844-50.
22. Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampin resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by Line Probe assay. J Clin Microbiol 1999; 37: 2663-6.